Attempts had already been made to investigate the potential of statins alone, or in combination with the SMO inhibitor cyclopamine, for the treatment of MB and other tumours thought to be dependent on HH pathway activity [89,123–126]. The gene discussed is SMO; the disease is neoplasm.